Pralatrexate
Back to searchMolecule Structure
Scientific Name
Pralatrexate
Description of the Drug
Pralatrexate is an antineoplastic agent used for the treatment of relapsed or refractory peripheral T-cell lymphoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06813
http://www.drugbank.ca/drugs/DB06813
Brand Name(s)
Folotyn
Company Owner(s)
Acrotech Biopharma Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dihydrofolate reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL202 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL21633 | |
DrugBank | DB06813 | |
PubChem: Thomson Pharma | 14761163 | 14907808 |
PubChem | 148121 | |
LINCS | LSM-45944 | |
Nikkaji | J557.257F | |
BindingDB | 50457437 | |
EPA CompTox Dashboard | DTXSID3048578 | |
DrugCentral | 4117 | |
Brenda | 77178 | 209749 |
ChemicalBook | CB31856065 | |
Guide to Pharmacology | 6840 | |
rxnorm | FOLOTYN | PRALATREXATE |
ChEBI | 71223 |